(Q33341376)

English

Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

autoimmune thrombocytopenic purpura

0 references

thrombocytopenia

1 reference

based on heuristic

inferred from title

author name string

Per-Ola Andersson

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Anna Olsson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Hans Wadenvik

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

862-867

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Antigen-driven bystander suppression after oral administration of antigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

An update on human Th1 and Th2 cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Evidence for a light chain restriction of glycoprotein Ib/IX and IIb/IIIa reactive antibodies in chronic idiopathic thrombocytopenic purpura (ITP).

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2002.03345.X

21 January 2018

Identifiers

10.1046/J.0007-1048.2002.03345.X

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33341376&oldid=1949523245"